Danaher Corporation

Danaher Teams With NVIDIA to Embed AI in Lab Instruments

Washington – October 14, 2026 -- Danaher Corporation (NYSE: DHR) has launched a collaboration with NVIDIA to combine its scientific instruments, automation technologies, laboratory workflow software and domain expertise with NVIDIA accelerated computing and AI, targeting faster movement from AI prediction to experimental evidence.

Danaher and NVIDIA build a closed loop between experiments and models

The companies aim to create a continuous learning cycle in which experimental results inform AI models and the models help design better experiments. Danaher says the goal is to reduce the time and complexity of turning an AI-generated prediction into the experimental evidence needed to act on it.

Exosomes Market to Hit $2.25B by 2034 on 28.8% CAGR

Image
Exosomes Market to Hit $2.25B by 2034 on 28.8% CAGR

Pune, India – – September 23, 2026 -- The global exosomes market is set to grow nearly tenfold over the next decade, expanding from USD 230.55 million in 2025 to USD 2,250 million by 2034, according to a new analysis from Maximize Market Research. The projected 28.8% compound annual growth rate between 2026 and 2034 places exosome technology among the fastest-expanding segments in biopharmaceutical R&D.

Drug delivery pipelines drive commercial momentum

Pharmaceutical and biotechnology companies are expanding exosome-related pipelines as the nanosized extracellular vesicles gain traction as targeted carriers for drugs, proteins, and RNA. Rising investment in biotechnology and advances in isolation, characterization, and engineering technologies are pushing exosomes beyond research settings into drug development and regenerative medicine applications.

Danaher Sets Q3 2026 Earnings Call for October 21

Washington – September 23, 2026 -- Danaher Corporation (NYSE: DHR) will hold its third-quarter 2026 earnings conference call on Wednesday, September 23, 2026, at 8:00 a.m. ET, the company confirmed.

Danaher to webcast hour-long Q3 results discussion on October 21

The call, lasting approximately one hour, will be webcast via the "Investors" section of Danaher's website under "Events & Presentations," alongside a slide presentation. Investors can dial in at 800-267-6316 within the U.S. or +1 203-518-9783 outside the U.S., using Conference ID DHRQ326.